[Osteomyelitis as a complication following BCG vaccination]. 1995

M I Withagen, and A Ruitenberg, and D van Soolingen, and H C Rümke, and A F Diepstraten, and R de Groot
Erasmus Universiteit, faculteit Geneeskunde, Rotterdam.

Osteomyelitis of the proximal femur was diagnosed in a 5-month-old girl after BCG vaccination at the age of 2 weeks. The diagnosis was confirmed by biochemical and molecular techniques (DNA fingerprinting). The girl responded well to antituberculous treatment.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D010019 Osteomyelitis INFLAMMATION of the bone as a result of infection. It may be caused by a variety of infectious agents, especially pyogenic (PUS - producing) BACTERIA. Osteomyelitides
D005260 Female Females
D005269 Femur The longest and largest bone of the skeleton, it is situated between the hip and the knee. Trochanter,Greater Trochanter,Lesser Trochanter,Femurs,Greater Trochanters,Lesser Trochanters,Trochanter, Greater,Trochanter, Lesser,Trochanters,Trochanters, Greater,Trochanters, Lesser
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D001500 BCG Vaccine An active immunizing agent and a viable avirulent attenuated strain of MYCOBACTERIUM BOVIS, which confers immunity to mycobacterial infections. It is used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity. Bacillus Calmette Guerin Vaccine,Calmette Guerin Bacillus Vaccine,Calmette's Vaccine,Calmette Vaccine,Calmettes Vaccine,Vaccine, BCG,Vaccine, Calmette's
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations
D016172 DNA Fingerprinting A technique for identifying individuals of a species that is based on the uniqueness of their DNA sequence. Uniqueness is determined by identifying which combination of allelic variations occur in the individual at a statistically relevant number of different loci. In forensic studies, RESTRICTION FRAGMENT LENGTH POLYMORPHISM of multiple, highly polymorphic VNTR LOCI or MICROSATELLITE REPEAT loci are analyzed. The number of loci used for the profile depends on the ALLELE FREQUENCY in the population. DNA Fingerprints,DNA Profiling,DNA Typing,Genetic Fingerprinting,DNA Fingerprint,DNA Fingerprintings,DNA Profilings,DNA Typings,Fingerprint, DNA,Fingerprinting, DNA,Fingerprinting, Genetic,Fingerprintings, DNA,Fingerprintings, Genetic,Fingerprints, DNA,Genetic Fingerprintings,Profiling, DNA,Typing, DNA,Typings, DNA

Related Publications

M I Withagen, and A Ruitenberg, and D van Soolingen, and H C Rümke, and A F Diepstraten, and R de Groot
January 1971, Acta orthopaedica Scandinavica,
M I Withagen, and A Ruitenberg, and D van Soolingen, and H C Rümke, and A F Diepstraten, and R de Groot
December 1995, Nederlands tijdschrift voor geneeskunde,
M I Withagen, and A Ruitenberg, and D van Soolingen, and H C Rümke, and A F Diepstraten, and R de Groot
January 1975, MMW, Munchener medizinische Wochenschrift,
M I Withagen, and A Ruitenberg, and D van Soolingen, and H C Rümke, and A F Diepstraten, and R de Groot
February 2012, Journal of Korean medical science,
M I Withagen, and A Ruitenberg, and D van Soolingen, and H C Rümke, and A F Diepstraten, and R de Groot
January 1986, Zeitschrift fur Orthopadie und ihre Grenzgebiete,
M I Withagen, and A Ruitenberg, and D van Soolingen, and H C Rümke, and A F Diepstraten, and R de Groot
January 1960, Acta tuberculosea Scandinavica,
M I Withagen, and A Ruitenberg, and D van Soolingen, and H C Rümke, and A F Diepstraten, and R de Groot
April 1978, Acta orthopaedica Scandinavica,
M I Withagen, and A Ruitenberg, and D van Soolingen, and H C Rümke, and A F Diepstraten, and R de Groot
March 2021, Malaysian orthopaedic journal,
M I Withagen, and A Ruitenberg, and D van Soolingen, and H C Rümke, and A F Diepstraten, and R de Groot
October 1965, Monatsschrift fur Kinderheilkunde,
M I Withagen, and A Ruitenberg, and D van Soolingen, and H C Rümke, and A F Diepstraten, and R de Groot
February 1981, Indian pediatrics,
Copied contents to your clipboard!